switching from tirzepatide to semaglutide for weight loss vs. Semaglutide: What You Should Know Semaglutide vs Tirzepatide for Weight

The importance of serine metabolism in cancer

Beyond its FDA-approved uses, gabapentin is frequently prescribed off-label for a broad spectrum of conditions where its nerve-calming properties can provide relief

Both of these are linked to a lower risk of metabolic syndrome

This does not included deaths that were reported in PIONEER 6, where 23 and 45 deaths were reported in the semaglutide of which 14 mg and placebo treatment groups, respectively, approximately half of which (10 and 23, respectively) were CV-related

therefore, the results may not be directly applicable to lower-risk populations with type 2 diabetes